Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Effect of heated humidification and topical steroids on compliance, nasal symptoms and quality of life in patients with obstructive sleep apnoea syndrome using nasal continuous positive airway pressure Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005
Long-term nCPAP compliance in patients with OSAS with initial in-hospital adjustment of nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Treatment of early undiagnosed airflow obstruction in patients of OSA on CPAP improves sleep quality and symptoms Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
Long-term effects of nasal budesonide administered to children with mild obstructive sleep-disordered breathing Source: Eur Respir J 2004; 24: Suppl. 48, 477s Year: 2004
Long-term outcome of nCPAP therapy in sleep apnoea patients Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
Nasal continuous airway pressure therapy and respiratory infections in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Initial acceptance and compliance to nasal CPAP in elderly patients Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009
Efficacy of intranasal corticosteroid therapy on lower respiratory tract responsiveness in children with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006
Objective compliance with oral appliance therapy versus CPAP in moderate obstructive sleep apnea Source: International Congress 2017 – CPAP therapy Year: 2017
The effects of ELTGOL on mucociliary clearance in patients with COPD Source: Eur Respir Rev 2006; 15: 192-193 Year: 2006
A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Effective patient compliance on nasal continuous positive airway pressure therapy supports an improvement in the quality of life in patients with obstructive sleep apnoea Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003
Nasal budesonide ameliorates symptoms and polysomnography findings in children with chronic nasal obstruction and mild sleep-disordered breathing Source: Eur Respir J 2003; 22: Suppl. 45, 391s Year: 2003
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 682s Year: 2006
Short effects of a pulmonary rehabilitation protocol on nasal mucociliary clearance in COPD patients Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009